Information Journal Paper
APA:
Copy. (2018). Aberrant cystatin-C expression in blood from patients with breast cancer is a suitable marker for monitoring tumor burden. ONCOLOGY LETTERS, 16(5), 5583-5590. SID. https://sid.ir/paper/669302/en
Vancouver:
Copy. Aberrant cystatin-C expression in blood from patients with breast cancer is a suitable marker for monitoring tumor burden. ONCOLOGY LETTERS[Internet]. 2018;16(5):5583-5590. Available from: https://sid.ir/paper/669302/en
IEEE:
Copy, “Aberrant cystatin-C expression in blood from patients with breast cancer is a suitable marker for monitoring tumor burden,” ONCOLOGY LETTERS, vol. 16, no. 5, pp. 5583–5590, 2018, [Online]. Available: https://sid.ir/paper/669302/en